NT5C2 and acute myeloid leukemia: Further evidences for the implication of NT5C2 in the cellular response to cytarabine came from the correlation between the formation of cytarabine triphosphate in blasts from patients with AML and their corresponding ratio of the expressions of DCK and NT5C2 [212].